other material
confidence medium
sentiment neutral
materiality 0.40
Aptevo Therapeutics extends poison pill expiration to Oct 2025, adjusts purchase price to $70
Aptevo Therapeutics Inc.
- Amendment No. 4 extends Rights Agreement Final Expiration Date to October 31, 2025.
- Purchase Price changed to $70 per one one-thousandth of a Series A Preferred Share.
- Rights Agreement originally dated November 8, 2020; Amendment modified rights of security holders.
- Entered into with Broadridge Corporate Issuer Solutions as Rights Agent.